drugset / Trial / NCT06832878
Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1.95 g | Oral |
Indications
No indication recorded.